Prevalence of Cardiovascular Morbidities in Myanmar
Overview
General Medicine
Authors
Affiliations
Background: Cardiovascular diseases (CVDs) are now in a rising trend in South East Asia including Myanmar due to increase in major cardiovascular risk factors in both urban and rural areas, such as smoking, obesity and diabetes mellitus. It is necessary to determine CVD morbidities in Myanmar for planning of prevention and control activities for CVDs. The cross-sectional household survey was conducted in 2012 with 600 people aged 40 years and above in four townships (Kyauk-Tan, Mawlamyaing, Pathein and Pyay) and used face-to-face interview with standard questionnaire [Rose Angina Questionnaire and Questionnaire by European Cardiovascular Indicators Surveillance Set (EUROCISS) Research Group] to determine the level of reported CVD morbidities in adult population.
Results: Age of the study population ranged from 40 to 99 years with the mean age of 56 years. Seventy-one percent of the study population was women. Nine percent of the study population have suffered from angina according to Rose Angina Questionnaire. Prevalence of possible heart attack, stroke and heart failure was 7.5, 1.5 and 2.8%. Prevalence of hypertension was 51%.
Conclusion: The CVD morbidities are high. There is a need for strengthening prevention and control activities of CVDs.
Tun K, Phyu Z, Tint N, Naung Z, Aung T Cureus. 2024; 16(10):e71690.
PMID: 39429988 PMC: 11488989. DOI: 10.7759/cureus.71690.
Win Z, Mao W, Traill T, Kyaw Z, Paing P, Ogbuoji O Lancet Reg Health Southeast Asia. 2024; 26:100394.
PMID: 38633709 PMC: 11022086. DOI: 10.1016/j.lansea.2024.100394.
Surveillance of stroke: a South-East Asia Region (SEAR) perspective.
Kalkonde Y, Rangamani S, Suwanwela N, Mathur P, Injety R, Sebastian I Lancet Reg Health Southeast Asia. 2023; 17:100286.
PMID: 37849929 PMC: 10577148. DOI: 10.1016/j.lansea.2023.100286.
Nozaki I, Shobugawa Y, Sasaki Y, Takagi D, Nagamine Y, Zin P Health Res Policy Syst. 2022; 20(Suppl 1):114.
PMID: 36443760 PMC: 9706823. DOI: 10.1186/s12961-022-00918-y.
Ismail S, Khalil M, Mohamad M, Shah S Front Cardiovasc Med. 2022; 9:921044.
PMID: 35958391 PMC: 9360484. DOI: 10.3389/fcvm.2022.921044.